MedPath

Comparison of visual outcome between two different Intraocular injections for swelling of nerve tissue of eye in patients with Intraocular lens

Phase 4
Conditions
Health Condition 1: H350- Background retinopathy and retinalvascular changes
Registration Number
CTRI/2022/03/040844
Lead Sponsor
Il
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Central subfield retinal thickness of at least 300um measured by OCT

2. Centre involving macular edema

3. Visual acuity between 6/9 to 6/60

Exclusion Criteria

1. Previous treatment in terms of : -

a) Focal/macular photocoagulation

b) Previous intravitreal injection therapy - Last 3 months

c) PRP in the last 6 months

2. Any medial opacity obscuring the fundus view

3. Intra ocular pressure >21mmHg or previous steroid responders

4. Cataract surgery and YAG capsulotomy in the last 3 months

5. PDRP patients requiring simultaneous pan-retinal photocoagulation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurement and comparison of average threshold for macular sensitivity via microperimetry between the two treatment arms <br/ ><br>Timepoint: 0, 1, 6 month <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Measurement and comparison of VA (snellenâ??s 3 metre), CSRT (OCT), fixation characteristics (microperimetry) and number of injections given between the two treatment arms <br/ ><br>Timepoint: 0, 1, 6 month
© Copyright 2025. All Rights Reserved by MedPath